Approximately 10% of the world population is infected with Entamoeba histolyfica, but only 10% of the carriers develop symptomatic amebiasis. This discrepancy could be explained by the genotypic differences between the morphologically indistinguishable invasive and noninvasive strains of E. histolytica currently identified by zymodeme analysis, a technique that is unsuitable for routine diagnostic laboratories. Here we report the production of a monoclonal antibody against E. histolytica and its use in an immunofluorescence assay to identify invasive isolates cultured from stool samples of infected patients in several regions where amebiasis is endemic: Bangladesh, Colombia, and Mexico. After testing a total of 88 E. histolytica isolates, the correlation between zymodeme characterization and the immunofluorescence assay with the invasive isolatespecific monoclonal antibody was 100%o. The epitope detected by the invasive isolate-specific monoclonal antibody resides in a previously undescribed internal protein with molecular masses of 84 and 81 kDa in axenic and polyxenic E. histolytica strains, respectively.
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Entamoeba histolytica is the etiological agent of human amebiasis. The infection is distributed worldwide, although the majority of cases are found in developing countries where fecal-oral transmission of E. histolytica cysts is facilitated by poor hygiene and the lack of clean water. The spectrum of clinical manifestations observed in infected individuals ranges from asymptomatic infection to intestinal and extraintestinal invasive disease. In 1984, it was estimated that approximately 10% of the world population was infected with E. histolytica and that only 10% of the infected subjects progressed to invasive amebiasis (47) . The discrepancy between the number of infected persons and the occurrence of invasive amebiasis seems to be due to the existence of two genetically different but morphologically indistinguishable parasites within the species. Brumpt (5) made this suggestion after infecting kittens with E. histolytica strains from asymptomatic carriers and observing no development of disease. He proposed a new nomenclature for the noninvasive and the invasive strains: Entamoeba dispar and Entamoeba dysenteriae, respectively. A few years later, Simic (36) infected kittens with E. histolytica strains from asymptomatic carriers and then passed these strains on to human volunteers. Neither the kittens nor the humans developed symptoms attributable to the infection.
More recently, Martinez-Palomo et al. (21) presence of the lectin concanavalin A, giving evidence for a phenotypic difference residing on the parasite membrane. Later, Sargeaunt and coworkers provided strong support for Brumpt's suggestion by showing, with more than 3,000 E. histolytica isolates, that zymodeme analysis clearly distinguished isolates cultured from asymptomatic patients and those cultured from patients with symptomatic amebic infection (31) (32) (33) .
On the basis of zymodeme characterization, other markers, such as resistance to complement-mediated lysis by human serum (28) , release of a neutral thiol proteinase (27) , overexpression of and structural differences between homologous cysteine proteinases (42) , and recognition by specific monoclonal antibodies (MAbs) (22, 24, 38, 40) and by specific DNA probes (4, 7, 13, 39, 41, with PBS-0.05% Tween 20-2% casein (PBST/C) (60 min at RT), washed (three times for 10 min each at RT in PBS-0.05% Tween 20), and probed with supernatant (1/2 dilution in PBST/C) or mouse ascites (1/100 dilution 1 h, RT) containing invasive isolate-specific MAb. After repeated washing, as described above, the membrane was exposed to a 1/2,000 dilution of peroxidase-conjugated rabbit anti-mouse immunoglobulin (no. 315-036-003; Jackson Immunoresearch Inc., Philadelphia, Pa.) in PBST/C (1 h, RT) and washed again (three times), and the protein bands were developed in 50 mM Tris-HCl (pH 7.4)-0.2 M NaCl-0.8% diaminobenzidine (no. 13033; BDH)-5% 4-chloro-1-naphthol (no. C-8890; Sigma)-0.006% H202 for 2 to 3 min.
RESULTS
Selection of an invasive isolate-specific MAb against E. histolytica. Nine of seventeen hybridoma cell lines initially selected by ELISA detected one or more bands on Western blots (Fig. 1A) . These nine cell lines were screened by IFA on fixed E. histolytica trophozoites, two of which (NIH:200 and SI) were from an invasive zymodeme and two of which (C29 and 8672) were from noninvasive zymodemes. MAb 20/7D, an immunoglobulin Gl mouse immunoglobulin, which detected a single band on the Western blots, in IFA recognized only the invasive E. histolytica trophozoites. This prompted us to test a larger number of reference (HM1:IMSS and SAW 1734) and clinical isolates from different areas of endemicity (Table 1) . MAb 20/7D reacted with all the invasive E. histolytica isolates and with none of the noninvasive isolates, including those isolates which were characterized by zymodeme and the four isolates which were characterized on clinical grounds only. The fluorescent patterns observed varied from patchy to homogeneous in the cytoplasm and were more intense in the nucleus and its membrane (Fig. 2) . The culture conditions (axenic or polyxenic isolates and liquid or biphasic medium) and the different methods of IFA slide preparation (parasites harvested from liquid medium or spotted directly from biphasic Robinson's medium with its accompanying mixture of starch and bacteria) did not affect the recognition of invasive E. histolytica by MAb 20/7D (Table 1) . Interestingly, with some polyxenic isolates, such as BOG-3, not all trophozoites on the slide reacted with the MAb, suggesting the presence of a heterogeneous cell population infecting the patient (Fig. 2) . MAb Fig. 2) and with HM-1:IMSS trophozoites fixed with glutaraldehyde but failed to react with live HM-1:IMSS trophozoites (data not shown). This suggests that the epitope recognized by MAb 20/7D is not exposed on the surface of the parasite.
In SDS-PAGE and Western blotting, MAb 20/7D recognized a single band with estimated molecular masses of 84 kDa in axenically grown and 81 kDa in polyxenically grown invasive E. histolytica (Fig. 1B) . This band appeared clearly in samples from all the invasive isolates tested and as a defined or very faint band in samples from the noninvasive isolates SAW 1734, BOG-1, and C29 (data not shown). DISCUSSION We have produced a MAb capable of distinguishing invasive strains of E. histolytica from noninvasive strains by IFA. So far, we have tested 88 E. histolytica isolates, comprising 6 reference and 82 clinical isolates, 78 characterized by zymodeme and 4 by clinical information only (see below). The clinical isolates were recovered from patients with symptomatic or asymptomatic infections from Bangladesh, Colombia, and Mexico, countries in which amebic infection is highly endemic (47) and which are widely separated geographically. Overall, the sensitivity and specificity of the IFA based on the invasive isolate-specific MAb 20/7D were both 100%.
The 78 clinical isolates characterized by zymodeme represent three different zymodemes, two invasive and one noninvasive, from a total of the six parent zymodemes reclassified by Blanc and Sargeaunt (3). These authors suggested such a reclassification after showing that the amount of starch in the culture medium produced variability in the isoenzyme electrophoresis patterns; this variability produced second-order zymodemes derived from the parent zymodemes. This variability together with the cost and time needed for the zymodeme analysis supports the use of (38, 40) . Recently developed objective attachments allow fluorescence microscopy to be performed with a standard light microscope in field conditions (20, 26) . We have also adapted MAb 20/7D to a capture ELISA for the detection of E.
histolytica antigen in feces (14a). Thus, if the IFA assay results are confirmed worldwide with all the zymodemes, zymodeme analysis can be reserved for reference laboratories.
The nonuniform reactivity of some clinical polyxenic isolates in IFA agrees with the concept that some patients can be infected with mixtures of E. histolytica strains, which requires cloning of the cultured parasites for reliable zymodeme analysis (31) . Direct visualization in the IFA eliminates the need for cloning. Alternatively, this nonuniform reactivity could be the result of differential or developmental regulation of the expression of the epitope by invasive strains in culture.
Considering the evolutionary distance between invasive and noninvasive strains (6), it is not surprising to find another antigenic difference that separates them. Nevertheless, MAb 20/7D recognizes an epitope with interesting features. The 81-and 84-kDa protein bearing the epitope is not equivalent to those already described (2, 22, 24, 27, 40, 44) . Furthermore, the fact that it is present in both invasive and noninvasive isolates, as shown by Western blotting, but differentially recognized by IFA suggests that this epitope is expressed and processed in such a way that it is accessible to MAb 20/7D only in nondenatured E. histolytica antigens of the invasive zymodemes. Once the protein has been denatured in SDS-PAGE, the epitope in noninvasive strains also becomes accessible to the MAb. Similar examples of cryptic epitopes unmasked by solubilization of proteins have been seen with the Rho(D) antigen of human erythrocytes (25) and membrane antigens of the parasites Leishmania tropica (16) and Trypanosoma cruzi (17) .
MAb 20/7D has been used to isolate a clone from a cDNA expression library of the E. histolytica invasive strain NIH: 200 (14a). This finding suggests that the reactivity of the epitope with the MAb does not depend on glycosylation of the protein, although glycosylation differences could explain the observed difference in molecular weights between the axenic and the polyxenic isolates studied. The binding of MAb 20/7D might reflect different biological properties such as pathogenicity, although it does not imply major structural differences, as the epitope is present in both strains. Quantitative studies on the expression of the protein in invasive and noninvasive E. histolytica strains and further compari- VOL. 30, 1992 on October 28, 2017 by guest http://jcm.asm.org/ Downloaded from in the axenic strains HK9 (14) and NIH:200 (43), isolated 39 and 43 years ago, respectively, and in the polyxenic cultures recently isolated from infected patients suggests that the protein bearing this epitope may be essential for the organism.
The invasive isolate 2788, from Bangladesh, was recovered from an asymptomatic carrier who could be a source for disease transmission if left untreated. Prospective epidemiological studies using MAb 20/7D would define more clearly the geographical distribution and the patterns of transmission of invasive strains and might allow focused intervention studies for particular regions, communities, or individuals.
Although the IFA results obtained with the clinical isolates for which zymodemes had not been determined also accorded with the invasive isolate-specific reactivity of MAb 20/7D, it is necessary to perform zymodeme analysis with cultured E. histolytica trophozoites from a more extensive series of isolates. Field studies are in progress to examine such a series of isolates including all known zymodemes.
A limited number of direct fecal smears from patients with dysentery have been examined by fluorescence microscopy after being probed with MAb 20/7D, with encouraging results (data not shown). If perfected, this technique would obviate the need to culture the parasite prior to identification of invasive organisms.
